Pfizer Inc. vs Samumed
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● Pfizer Inc.● Samumed
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Pfizer Inc. PFE · #126 in the world | Samumed |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 1849 | 2008 |
| Size | ||
| Market cap | $170.7 B | — |
| Revenue | $62.6 B | — |
| Net income | $7.8 B | — |
| Employees | 75,000 | — |
| Valuation | ||
| P/E ratio | 42.3× | — |
| Price to sales | 2.7× | — |
| Price to book | 2.0× | — |
| Free cash flow yield | 5.3% | — |
| Profitability | ||
| Gross margin | 74.3% | — |
| Net margin | 12.4% | — |
| Return on equity | 8.9% | — |
| Growth | ||
| Revenue growth | -1.6% | — |
| Revenue growth, 3 years a year | -14.8% | — |
| Earnings per share growth | -3.5% | — |
| Financial strength | ||
| Debt to equity | 0.7× | — |
| Cash | ||
| Free cash flow margin | 14.5% | — |
| Strength scores | ||
| Piotroski F-score | 5 of 9 | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap — |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
More about Pfizer Inc.
More about Samumed
Sources#
Every figure on this page comes from these, with the date shown next to it.